GSUN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Golden Sun Education Group Ltd · Consumer Defensive · Education & Training Services

Open interactive chart View report data
Latest close 0.39 USD
84.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -40.4% below the Trend Line and sits at 6.8% of its 52-week range. The latest completed week returned 84.4%, after a 5.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100.

Setup score 32 out of 100
Latest Close 0.39 USD 31 Jul 2026
1W Return 84.4% latest completed week
4W Return 5.6% short-term follow-through
12W Return -27.6% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 4.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 38.86% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 84.4% Latest completed week; four-week move 5.6%. Indicator stack 0/60 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.86% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 48/100 29 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -40.4% below the Trend Line and sits at 6.8% of its 52-week range. The latest completed week returned 84.4%, after a 5.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 4.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.6% over four weeks, -27.6% over 12 weeks, and -83.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W84.4%
4W5.6%
12W-27.6%
26W-65.6%
52W-83.7%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.59Latest activity-pressure read.
Pressure change-8.8%Four-week change in activity pressure.
Leadership-73.56Latest relative-leadership reading.
RS change7.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 76% Model confidence 62%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength59/100Blend of value, momentum, and quality. Underlying universe rank 42; rank 1 is best.
Value54/100Relative valuation strength. Underlying universe rank 47; rank 1 is best.
Quality52/100Profitability and accounting quality. Underlying universe rank 49; rank 1 is best.
Momentum54/100Medium-term price momentum. Underlying universe rank 47; rank 1 is best.
Growth54/100Revenue and earnings growth. Underlying universe rank 47; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-154.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
2.3%
Gross profit retained from each unit of revenue.
Operating margin
-5.9%
Operating profit retained from revenue.
Free-cash-flow margin
-26.2%
Free cash flow generated from revenue.
Return on invested capital
-12.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 29 relevant articles.

5 positive · 20 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-88.4%Distance below the 52-week high.
13-week volatility27.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+84.4%Week of 31 Jul.
Worst week-58.1%Week of 13 Mar.
Latest week+84.4%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains1
Flat weeks0
Modest losses3
Sharp losses13
Recent vol27.8%13-week weekly-return volatility.
Base vol21.3%52-week weekly-return volatility.
Up/down split19/32Count of positive and negative weeks in the 52-week window.
Average skew17.3% / -12.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.12; No reversal markers Next-Week ExpectancyNegative 38.86%

Next-week expectancy is negative with a 38.86% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 48 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment48/100

Weighted news tone is neutral across 29 relevant articles.

Golden Sun Health Technology Group Ltd (GSUN) Dividends & Stock Splits: Historical Payouts and Event Timeline Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.39 USD84.4%0.65 USD3.82 USD0.59-73.56190.8MOff
24 Jul 20260.21 USD-32.8%0.67 USD3.87 USD0.56-86.05210.3MOff
17 Jul 20260.31 USD-23.2%0.70 USD3.92 USD0.61-80.362.4MOff
10 Jul 20260.41 USD11.0%0.74 USD3.98 USD0.74-76.392.9MOff
3 Jul 20260.36 USD-6.4%0.77 USD4.03 USD0.65-79.23129.1MOff
26 Jun 20260.39 USD-19.3%0.81 USD4.09 USD0.55-78.27695.6KOff
19 Jun 20260.48 USD17.8%0.84 USD4.16 USD0.41-75.011.4MOff
12 Jun 20260.41 USD-0.5%0.87 USD4.23 USD0.23-78.972.3MOff
5 Jun 20260.41 USD-2.9%0.91 USD4.30 USD0.21-79.16867.9KOff
29 May 20260.42 USD0.2%0.97 USD4.38 USD0.20-80.22143.4KOff
22 May 20260.42 USD-1.6%1.03 USD4.45 USD0.23-80.36120.8KOff
15 May 20260.43 USD-19.1%1.10 USD4.52 USD0.29-80.54332.9KOff
8 May 20260.53 USD-7.0%1.17 USD4.58 USD0.04-76.837.1MOff
1 May 20260.57 USD-17.2%1.24 USD4.65 USD-0.20-74.653.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.